IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 45 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $138 | -99.9% | 396,871 | -0.2% | 0.00% | – |
| Q3 2022 | $148,000 | -18.7% | 397,803 | 0.0% | 0.00% | – |
| Q2 2022 | $182,000 | -2.2% | 397,803 | +6.5% | 0.00% | – |
| Q1 2022 | $186,000 | -12.3% | 373,483 | 0.0% | 0.00% | – |
| Q4 2021 | $212,000 | -44.8% | 373,483 | 0.0% | 0.00% | – |
| Q3 2021 | $384,000 | -0.3% | 373,483 | +16.4% | 0.00% | – |
| Q2 2021 | $385,000 | +14.9% | 320,850 | +24.1% | 0.00% | – |
| Q1 2021 | $335,000 | -54.7% | 258,451 | +28.1% | 0.00% | – |
| Q4 2020 | $740,000 | +93.7% | 201,731 | +12.7% | 0.00% | – |
| Q3 2020 | $382,000 | +19.4% | 178,959 | 0.0% | 0.00% | – |
| Q2 2020 | $320,000 | +35.6% | 178,959 | 0.0% | 0.00% | – |
| Q1 2020 | $236,000 | -63.7% | 178,959 | -50.0% | 0.00% | – |
| Q4 2019 | $650,000 | +25.7% | 357,918 | +100.0% | 0.00% | – |
| Q3 2019 | $517,000 | +7.7% | 178,959 | -0.6% | 0.00% | – |
| Q2 2019 | $480,000 | -26.0% | 180,058 | -29.3% | 0.00% | – |
| Q1 2019 | $649,000 | -49.1% | 254,653 | -44.8% | 0.00% | – |
| Q4 2018 | $1,276,000 | -35.5% | 461,154 | +107.6% | 0.00% | -100.0% |
| Q3 2018 | $1,978,000 | -12.4% | 222,109 | -87.0% | 0.00% | 0.0% |
| Q2 2018 | $2,258,000 | – | 1,711,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |